![Charles Pitman-King](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Charles Pitman-King is currently VP of European Pharmaceuticals Equity Research at Barclays Capital Securities Ltd. since 2022.
Formerly, Mr. Pitman-King was an Equity Research Analyst at Rothschild & Co Global Markets Solutions Ltd. from 2016 to 2022.
Aktive Positionen von Charles Pitman-King
| Unternehmen | Position | Beginn |
|---|---|---|
Barclays Capital Securities Ltd.
 Barclays Capital Securities Ltd. Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01.09.2022 |
Ehemalige bekannte Positionen von Charles Pitman-King
| Unternehmen | Position | Ende |
|---|---|---|
Redburn (Europe) Ltd.
 Redburn (Europe) Ltd. Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01.07.2022 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
92
Beziehungen ersten Grades
2
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Barclays Capital Securities Ltd.
Barclays Capital Securities Ltd. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Redburn (Europe) Ltd.
Redburn (Europe) Ltd. Investment Banks/BrokersFinance Provides brokerage services | Finance |
